Navigation Links
Isotechnika's Lead Drug, ISA247, To Be Highlighted at the,Association for Research in Vision and Ophthalmology (ARVO) Annual,Meeting

e of our partners, Lux Biosciences, has received permission from the Food and Drug Administration to investigate ISA247 in three separate pivotal Phase 2/Phase 3 trials for the treatment of non-infectious uveitis and as a maintenance therapy in uveitis.

Isotechnika Inc. is a publicly traded company on the Toronto Stock Exchange under the symbol "ISA". More information on Isotechnika can be found at www.isotechnika.com.

Partnerships with Isotechnika Inc.

Isotechnika Inc. signed a collaboration agreement with Hoffman La Roche on April 9, 2002, which licensed the worldwide rights to develop and commercialize voclosporine for all transplant indications.

On September 30, 2005, Isotechnika Inc. entered into an exclusive worldwide licensing agreement with Atrium Medical Corporation for the use of voclosporine and TAFA93 specifically with drug eluting devices for the non-systemic treatment of vascular, cardiovascular, target vessel and tissue disorders.

Isotechnika Inc. and Cellgate Inc. signed an option agreement on April 25, 2006, granting Isotechnika the option to obtain an exclusive license to develop and commercialize conjugates consisting of Cellgate's patented transporter technology for the topical delivery of voclosporine in patients suffering from mild to moderate psoriasis.

On May 25, 2006, Isotechnika Inc. signed an agreement with Lux Biosciences, Inc. of Jersey City, New Jersey granting Lux Biosciences worldwide rights to develop and commercialize Isotechnika’s lead drug, voclosporine for the treatment and prophylaxis of all ophthalmic diseases.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements, including the Company's belief as to the potential of its products, the Company's expectations regarding the issuance of additional patents a
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
4. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting
7. Alfacells Onconase Highlighted in Latest Edition of Handbook of Therapeutic Antibodies
8. NIEHS Researchers Identify Enzyme Critical in DNA Replication
9. Stanford Researchers Find Brain Pathway of Depression in Rats
10. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
11. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
Post Your Comments:
(Date:10/6/2008)...ard-winning video clips feature children, parents ... studies, BETHESDA, Md., Oct. 6 /PRNewswire-USNew...cines, research in children saves lives and improv...m the National Institutes of,Health (NIH), "Childr...linicalStudies.nhlbi.nih.gov ), offers parents and...
(Date:10/6/2008)...ata from SONIC Trial Showed REMICADE Therapy is Mo...ucosal Healing Compared with Standard ...la., Oct. 6 /- Data presented for the...th Crohn,s Disease Naive to,Immunomodulators and B...nto,the approach to care of patients with moderate...
(Date:10/6/2008)... - Conference Call Scheduled for 9:00 AM E... -- Dendreon Corporation (Nasdaq:,DNDN) announced ...alysis of,the Phase 3, randomized, double-blind, p...te AdenoCarcinoma Treatment, also known as D9902B)...efficacy of the,investigational active cellular im...
(Date:10/6/2008)...esign Concept of Other Product - Company,s Bioabso...posium, HONG KONG, Oct. 6 /- Data fr...ro-healing stent, OrbusNeich,s Genous Bio-engineer...nscatheter Cardiovascular,Therapeutics symposium, ... M.D., Ph.D., of the Academic Medical Center in,Am...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference 15186 1Mens Health Guide for Ages 40 60 Launched by NHS Choices 15182 1Researchers urge ethics guidelines for human genome research 15179 1Researchers urge ethics guidelines for human genome research 15179 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 1AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 2AT 26T Announces Grant to Center on Aging University of Miami Miller School of Medicine 15177 3
(Date:10/6/2008)...t against childhood obesity, researcher notes , ...ee-quarters of middle schools have vending machine...study finds. , The research demonstrates that t...and "that those vending machines don,t always have...rus, a registered dietitian with the Center for Ob...
(Date:10/6/2008)...wire-FirstCall/ -- HealthSouth,Corporation (NYSE: ...ly,publicized investor meeting in New York City. P...30 a.m. EST at the Grand Hyatt New York, located a... follows:, 8:00 a.m. Continental Breakfast 8...ive Officer -- HealthSouth Overview a...
(Date:10/6/2008)...nel and their family members can take,anonymous on...STON, Oct. 6 /PRNewswire-USNewswire/ -- Military l...their families that are unique and,difficult. Some...atters get,worse and one problem can trigger other...check things out to see what is really happening.,...
(Date:10/6/2008)...University of California, San Diego School of Medi...ts bolsters production of a protective chemical no...n infections that are a common result of atopic de...study led by Richard Gallo, M.D., Ph.D., professo...logy at the UCSD School of Medicine and the Dermat...
Breaking Medicine News(10 mins):Health News:Vending Machines Found in Most Middle Schools 2Health News:HealthSouth to Hold Investor Meeting November 10, 2008 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2
...artmouth Medical School investigators are learning...levels found in drinking water in many areas of th...aper published online on Dec. 2 in the journal Che...ort that three different steroid hormones all show...
... new study finds that the anti-craving drug, Naltr... negative moods and women who are trying to quit s...st step towards individualized medicine, scientist...nicotine addiction and in treatment. Researchers...
...n experimental epilepsy drug, lacosamide, develope... reducing the frequency of seizures in patients// ...n Monday following the results of a phase 3 trial....were presented at the North American Regional Epil...
... Canadian Study finds that adolescence boys are at... the same age.// Researchers have found that the s...before adulthood. Cardiologists say that smoking, ...ome of the factors for the cause of high blood pre...
Other Medicine News:Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 2Health News:Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc 3Health News:Teen Boys At Greater Risk To High Blood Pressure Than Girls 2
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: